thyroid eye disease
Endocrinology · 2025–2025
1decision
1medicine
1carried consumer input
11individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| teprotumumab Treatment of active, moderate-to-severe thyroid eye disease (TED). An autoimmune inflammatory disorder affecting the orbit and periorbital tissues, most… | May 2025 | Not recommended | 11 individuals Global Healthy Living Foundation Australia · Australian Thyroid Foundation |
Who spoke
Global Healthy Living Foundation Australia · Australian Thyroid Foundation
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.